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Abstract The multiplication of vesicular stomatitis virus in
HeLa cells was inhibited by treating the cells with tumor necrosis
factor (TNF). Comparison of the kinetics of virus multiplication
and that of virus-induced apoptosis in the TNF-treated cells
revealed that the antiviral effect of TNF is accompanied by a
rapid induction of apoptosis in the cells upon infection,
suggesting that TNF can inhibit virus multiplication by accel-
erating an apoptotic response in the infected cells.
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1. Introduction
Virus infection induces a group of cytokines which mediate
an in£ammatory reaction at the site of the infection. Tumor
necrosis factor (TNF) is one of these in£ammatory cytokines
and is considered to take some roles in a host defense mech-
anism by interacting with a variety of immune and non-im-
mune cells [1]. This cytokine can suppress the multiplication
of viruses in the infected cells directly like the action of an
interferon [2^5], although the mechanism of this antiviral ac-
tivity has not yet been elucidated. No speci¢c step in virus
multiplication has been found to be inhibited by TNF.
Apoptosis or programmed cell death is one type of animal
cell death in which cells die by an active cellular process under
the genetic control of the cells (‘death program’) [6]. Although
many animal viruses are known to induce an apoptotic re-
sponse in infected cells, the signi¢cance of virus-induced apop-
tosis is not yet clear [7]. Previous studies on the e¡ects of
apoptosis on the in vitro replication and the in vivo infectivity
of a baculovirus revealed that a host apoptotic response pro-
vides protection against virus infection at the organismal level
[8], suggesting that the virus-induced apoptosis can have some
role in a host defense mechanism [9,10]. In agreement with
this hypothesis, apoptotic cell death concomitantly brings an
abortion of the progeny virus production in some cases of
animal virus infections in vitro [11^13], although there are a
number of exceptions, especially in the infection with RNA
viruses [14^17].
To understand the antiviral mechanism of TNF, we char-
acterized the multiplication of vesicular stomatitis virus (VSV)
in TNF-treated HeLa cells in relation to the kinetics of virus-
induced apoptosis in host cells.
2. Materials and methods
2.1. Cells and virus
HeLa cells were grown in minimal essential medium with Earle’s
salts (MEM) supplemented with 10% newborn bovine serum. VSV
(New Jersey strain) was used throughout the experiments.
2.2. Cytokine treatment
Recombinant TNF-K and recombinant consensus interferon K were
kindly provided by Amgen (Thousand Oaks, CA, USA). Cytokine
treatment and virus infection were carried out as follows: con£uent
monolayers of HeLa cells were preincubated in MEM containing
0.1% bovine serum albumin (BSA) and TNF or interferon K for about
16 h. The treated cells were infected with VSV at a multiplicity of
infection (MOI) of 10 or 12 by essentially the same procedure as
described previously [17,18]. The infected cells were incubated in the
medium containing BSA and cytokine for the indicated period.
2.3. Detection of apoptosis
The morphology of cell nuclei and the fragmentation of chromoso-
mal DNA were examined by the methods described previously [19].
3. Results
3.1. E¡ect of TNF on virus multiplication in HeLa cells
Fig. 1 shows the antiviral activity of TNF-K in comparison
with that of interferon K. When HeLa cells were infected with
VSV, the progeny virus yields decreased with increasing con-
centrations of the agent in the TNF-treated cells, although not
so markedly as with interferon. Although TNF can induce the
synthesis of interferon in some cells [1], the observed antiviral
activity of TNF is not mediated by the production of inter-
feron, because the addition of anti-interferon serum did not
a¡ect this activity of TNF (data not shown). In addition, the
TNF-treated cultures usually showed stronger cytopathic ef-
fects (CPE) by the virus infection than the untreated cultures
(see below) while the CPE of interferon-treated cultures was
markedly suppressed. The clear di¡erence in the CPE between
TNF- and interferon-treated cells supports that the antiviral
mechanism of TNF and that of interferon are distinct.
3.2. Virus growth in TNF-treated cells
Fig. 2 shows the one-step growth curve of VSV in the TNF-
treated and untreated Hela cells. In the untreated cells, the
progeny virus substantially appeared at 4 h post infection
(p.i.) in the culture medium, increased with time and reached
a plateau after 10 h p.i. In the TNF-treated cells, the progeny
virus appeared at the same time p.i. as in the untreated cells,
but gradually stopped increasing; the ¢nal yield under the
conditions (100 units TNF-K/ml) was approximately one tenth
of that in the untreated cells. In addition, although incubation
of HeLa cells with TNF-K does not induce signi¢cant mor-
phological changes of the cells, the TNF-treated cultures
showed stronger CPE upon infection with VSV than the un-
treated cultures, e.g. a shrinkage of the infected cells and
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plasma membrane blebbing and ballooning (data not shown).
These morphological characteristics are known to be those of
apoptotic cells.
3.3. Nuclear morphology of infected cells
Apoptosis has been de¢ned morphologically by cell shrink-
age and nuclear fragmentation and biochemically by fragmen-
tation of chromosomal DNA into nucleosomal oligomers [6].
As reported previously [17], infection with VSV induces mas-
sive apoptosis in the infected cells. Fig. 3 shows the morphol-
ogy of the infected cell nuclei at various times after infection.
Although even uninfected HeLa cells (Fig. 3A) usually con-
tain a small fraction of apoptotic cells, a signi¢cant amount of
infected cells with unusual condensation of chromatin ap-
peared at 3 h p.i. in the TNF-treated cells (Fig. 3B); the
chromatin condensation as well as the fragmentation of in-
fected cell nuclei became very evident at 4 h p.i. (Fig. 3C). In
contrast, the apoptotic cells appeared at about 4 h p.i. in the
control culture without TNF treatment (Fig. 3D). At 6 h p.i.,
both the TNF-treated (Fig. 3E) and untreated (Fig. 3F) cells
showed large numbers of apoptotic cells in the infected cul-
ture. The treatment of HeLa cells with TNF alone (without
infection) did not induce these morphological characteristics
of apoptosis (data not shown).
3.4. DNA fragmentation in infected cells
In agreement with these results, the degradation of chromo-
somal DNA into oligonucleosome-sized fragments occurred
with a shorter incubation period in the TNF-treated cells
than in the untreated cells. Fig. 4A shows that the character-
istic DNA ladder was clearly visible at 5 h p.i. in the TNF-
treated cells, while it was visible but not so evident at 5 h p.i.
in the untreated cells. To determine the detailed kinetics of
this increase in the amount of chromosomal DNA extracted
in the fragmented DNA fraction, cellular DNA was labeled
with [3H]thymidine prior to virus infection; at the indicated
intervals after infection, the radioactivities in fractions of total
and extracted DNA were determined separately and the rela-
tive amounts of fragmented DNA in the total DNA were
calculated. As shown in Fig. 4B, the amount of fragmented
DNA started increasing at approximately 4 h p.i. and reached
a plateau at 8 h p.i. in the untreated cells, as reported pre-
viously [17]. In contrast, the increase started at 3 h p.i. and
was completed at approximately 6 h p.i. in the TNF-treated
cells, indicating that, when the TNF-treated cells were infected
with VSV, the virus-induced apoptosis occurred with an in-
cubation period 1 h shorter than in the untreated cells.
To examine the e¡ect of apoptosis on the multiplication of
VSV, we prepared apoptotic cells by treating the cells with 1 M
sorbitol [19]. Although VSV could grow in these apoptotic
cells with an almost similar eclipsed period an in the untreated
normal cells, virus multiplication was obviously suppressed;
the ¢nal yield of progeny virus decreased to below one ¢fth of
the normal cells.
4. Discussion
Cells of most cell types express TNF receptors on their
surface. After binding to these receptors, TNF can activate
signal transduction pathways to induce pleiotropic biological
e¡ects, including apoptosis, antiviral activity, and activation
of the transcription factor NF-UB [20]. As shown in Fig. 1, the
multiplication of VSV is suppressed dose-dependently in
TNF-treated HeLa cells, although Mestan et al. [3] described
in their earlier work, without showing experimental data, that
VSV can grow normally in TNF-treated HeLa cells. To elu-
cidate the mechanism of antiviral activity of TNF, we char-
acterized the kinetics of virus growth in relation to that of
virus-induced apoptosis in the TNF-treated cells.
Previously we showed that VSV can induce massive apop-
tosis in infected cells and the production of progeny virus
occurred with almost the same kinetics as that of DNA frag-
mentation, indicating that the production of progeny virus is
limited after the induction of the apoptotic response in in-
fected cells. From these results we concluded that, by a rapid
multiplication after infection, VSV can escape apoptotic cell
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Fig. 1. Antiviral e¡ect of TNF-K and interferon K. HeLa cells were
incubated in MEM containing 0.1% BSA and various concentra-
tions of TNF-K (a) or interferon K (O) for 14 h prior to the infec-
tion. The cells were infected with VSV at an MOI of 12 and were
incubated in the medium with the same concentrations of the cyto-
kine. Virus yields were determined by measuring the amounts of
progeny virus in the culture medium at 8 h p.i.
Fig. 2. One-step growth curve of VSV in the TNF-treated and un-
treated cells. HeLa cells were incubated with TNF-K (100 units/ml)
for 16 h prior to the infection. The cells were infected with VSV at
an MOI of 10 and were incubated in the presence (b) or absence
(a) of TNF-K. At intervals, the amounts of the progeny virus in
the medium were determined.
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damage and the resulting suppression of virus growth in per-
missive host cells [17]. In the present study, we demonstrated
that treatment of HeLa cells with TNF causes the cells to start
apoptosis with a 1 h shorter incubation period after the onset
of infection (Figs. 3 and 4). Although we do not know how
critical this 1 h period is for the multiplication of VSV, the
observed restriction in virus multiplication can be the result of
the earlier onset of the apoptotic response in TNF-treated
cells, because the multiplication of VSV is impaired in apop-
totic cells.
However, the results in Figs. 3 and 4 also indicate that not
all cells showed the characteristics of apoptotic cells (i.e. mor-
phology of cell nuclei and fragmentation of chromosomal
DNA). This heterogeneity in the apoptotic response of in-
fected cells is probably due to heterogeneity in the stages of
virus multiplication in each cell in these infected cell popula-
tions. In addition, it should be noted that the observed heter-
ogeneity cannot exclude that apoptosis was induced in all cells
in these cultures, because quantitation of cells dying through
the apoptotic pathway is di⁄cult ; the characteristic marker
currently available to detect apoptosis is almost the ¢nal out-
come of biological processes toward programmed cell death.
Further characterization of the apoptotic pathway is neces-
sary to detect a key step in a speci¢c aspect (e.g. antiviral
e¡ect) of apoptosis; at least, it is obvious that the multiplica-
tion of VSV is not inhibited directly by the nuclear fragmen-
tation or degradation of chromosomal DNA, because VSV
can grow even in enucleated cells [21].
Although we cannot exclude the possibility that the ob-
served acceleration of apoptosis does not a¡ect virus multi-
plication and is independent of the observed restriction of
virus multiplication by TNF, this possibility is less likely be-
cause (1) the multiplication of VSV is restricted in apoptotic
cells and (2) essentially the same results were obtained with
in£uenza virus-infected MDCK cells ; in£uenza virus A/Aichi
induces apoptosis with a shorter incubation period in TNF-
treated cells than in untreated cells with a concomitant reduc-
tion of the progeny virus yield (Koyama, unpublished results).
These results are most consistent with the idea that the accel-
eration of apoptosis accounts for the observed restriction of
virus multiplication in the TNF-treated cells.
Previous studies by us and others revealed that VSV and
in£uenza virus induce an apoptotic response in cells fully per-
missive for virus multiplication, suggesting that the virus-in-
duced apoptosis itself seems not to have any deleterious e¡ect
on the multiplication of these viruses in vitro [14,16,17]. How-
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Fig. 3. Morphology of the infected cell nuclei. See legend to Fig. 2. The infected cells were ¢xed with methyl alcohol/acetic acid (3:1) and
stained for 10 min with the DNA binding dye Hoechst 33258 (0.05 Wg/ml) according to the method of McGarrity [22]. A: Uninfected control
without TNF treatment. B: TNF-treated cells at 3 h p.i. C: TNF-treated cells at 4 h p.i. D: Untreated cells at 4 h p.i. E: TNF-treated cells at
6 h p.i. F: Untreated cells at 6 h p.i.
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ever, the present study suggests that, in vivo, virus-induced
apoptosis probably has a certain role in a host defense mech-
anism against these RNA viruses in combination with TNF,
one of the representative in£ammatory cytokines.
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Fig. 4. DNA fragmentation in VSV-infected cells. [3H]Thymidine-la-
beled HeLa cells were treated with TNF-K and infected with VSV
as described in the legend to Fig. 2. At the indicated intervals, the
cells were harvested and the fragmented DNA was extracted, pre-
cipitated and analyzed in a 1.5% agarose gel (A). For the quantita-
tive analysis, the radioactivities in fractions of total and fragmented
DNA of the TNF-treated (b) or untreated (a) cells were determined
separately as described previously [19].
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